USPTO serial 79337412
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Eric Lamb
Eric Lamb Frost Brown Todd LLP111 Monument Circle, Suite 4500Indianapolis, IN 46204United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Assays and reagents for scientific or medical research purposes | ACTIVE | — |
| 005 | Pharmaceutical preparations for the treatment of acute and chronic diseases, infectious diseases, hereditary diseases, dietary and metabolic deficiency disorders, and physiological disorders; medical preparations for the treatment of acute and chronic diseases, infectious diseases, hereditary diseases, dietary and metabolic deficiency disorders, and physiological disorders; chemical preparations for medical purposes, namely for the treatment of acute and chronic diseases, infectious diseases, hereditary diseases, dietary and metabolic deficiency disorders, and physiological disorders; chemical reagents for medical use; diagnostic preparations, substances, agents, reagents and assays for medical purposes; diagnostic testing preparations, substances, agents, reagents and assays for medical purposes, namely, for testing blood, body fluids, blood derivatives and body fluids derivatives | ACTIVE | — |
| 009 | Scientific apparatus and instruments, namely, devices for collecting, storing, processing, transferring, testing, analysing and monitoring liquid samples, blood, body fluids, blood derivatives and body fluid derivatives; scientific research and laboratory apparatus and instruments, namely, diagnostic devices for detecting pathogens and biomarkers in blood, body fluids, blood derivatives and body fluid derivatives for clinical research and scientific purposes; material testing apparatus and instruments, namely, analysers and cartridges for testing chemical, biological and environmental samples for clinical research and scientific purposes; apparatus and instruments for transmission of communication; monitoring, measuring, signalling and control apparatus and instruments, namely, electronic measuring instruments for use in electrochemical analysis, potentiostats, galvanostats and impedance analyzers; audio-visual receivers; computer apparatus and instruments, namely, computer hardware and peripheral apparatus for clinical research and scientific purposes; downloadable computer software for operating analytical and diagnostic devices for clinical research purposes and for scientific, veterinary and medical purposes; downloadable computer application software for management of patient data, healthcare workflow and connectivity between patients and healthcare providers; integrated computerized system for data capture, collection, recording, processing, transmission, reproduction, storage and/or communications; parts and fittings for all the aforementioned goods | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, wearable devices for patient vital signs, blood and sweat properties and physical movement monitoring, and devices for collecting, storing, processing, transferring, testing, analysing and monitoring liquid samples, blood, body fluids, blood derivatives and body fluid derivatives for medical purposes; medical diagnostic apparatus and instruments, namely, diagnostic devices for detecting pathogens and biomarkers in blood, body fluids, blood derivatives and body fluid derivatives and reporting in relation to the same; testing apparatus and instruments for medical and/or medical diagnostic purposes, namely, analysers and cartridges for use in diagnosing and/or monitoring acute and chronic diseases, infectious diseases, hereditary diseases, dietary and metabolic deficiency disorders, and physiological disorders; medical diagnostic testing apparatus and instruments for the measurement of clinical biomarkers; parts and fittings for all the aforementioned goods | ACTIVE | — |
| 025 | Clothing, namely, shirts, pants, coats, coveralls, dresses and jackets; footwear; headgear namely hats, caps as clothing, and headwear | ACTIVE | — |
| 041 | Education services, namely, providing seminars, non-downloadable webinars, conferences and classes about clinical research, science, medical and veterinary diagnostics, patient health and wellbeing; training services in the field of clinical research, science, medical and veterinary diagnostics, patient health and wellbeing; research in the field of education; publishing services of books, electronic books, guides, workbooks, newsletters, manuals and brochures; publishing services, namely publishing of veterinary publications; publication of medical and/or scientific publications; consultancy, advisory and information services relating to or connected with the aforementioned services | ACTIVE | — |
| 042 | Research and development of new products for others; medical research and development services; scientific research and development services; pharmaceutical research and development services; new product design services; design of research, scientific and diagnostic apparatus and instrument products for others; design of new products, namely, pharmaceutical preparations; design of new products, namely, veterinary preparations; design of new products, namely, diagnostic preparations, substances, agents, reagents, and assays; research, design and development of medical apparatus and instrument products; research, design and development of medical diagnostic apparatus and instrument products; research, design and development of diagnostic test products for the measurement of clinical biomarkers; software research, design and development services; consultancy, advisory and information services relating to or connected with the aforementioned services | ACTIVE | — |
| 044 | Medical services; medical diagnostic testing, analysing, monitoring and reporting services; medical testing, screening and analysis services relating to the diagnosis and/or treatment of disease, namely acute and chronic diseases, infectious diseases, hereditary diseases, dietary disorders, metabolic deficiency disorders, and physiological disorders; consultancy, advisory and information services relating to or connected with the aforementioned services | ACTIVE | — |
| 045 | Intellectual property licensing services; licensing of technology products and software; licensing of manufacturing technology products, software and manufacturing processes; licensing of intellectual property and/or intellectual property rights; licensing of industrial property products, software and industrial property rights; licensing of patents, confidential information, technical information and know-how; consultancy, advisory and information services relating to or connected with the aforementioned services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 11, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 16, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 16, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 15, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 8, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 8, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 8, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 2, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 15, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 15, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 30, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 30, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 30, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 10, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 10, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 10, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 24, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 20, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 20, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 20, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 20, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 23, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 23, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 23, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 8, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 15, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 15, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 26, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 25, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 22, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 12, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 8, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 7, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |